| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,246,743 | 1,159,195 | 1,121,307 | 1,145,214 | | Cost of Revenue | 1,061,847 | 995,782 | 956,971 | 968,719 | | | Gross Profit | 184,896 | 163,413 | 164,336 | 176,495 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 126,282 | 122,173 | 135,452 | 133,466 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 58,614 | 41,240 | 28,884 | 43,029 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| (204) | (735) | | Earnings Before Interest And Taxes | 37,840 | 41,240 | 28,680 | 42,294 | | Interest Expense | (14,129) | 6,949 | 7,180 | 8,440 | | Income Before Tax | 51,969 | 34,291 | 21,500 | 33,854 | | Income Tax Expense | 18,501 | 13,133 | 7,979 | 11,299 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 33,468 | 21,158 | 13,521 | 22,555 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 33,468 | 21,158 | 13,521 | 22,555 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $33,468 | $21,158 | $13,521 | $22,555 |
|
0.01% Nasdaq 
Income Statement
